Abstract
Mutations with large fitness benefits and mutations occurring at high rates may both cause parallel evolution, but their contribution is predicted to depend on population size. Moreover, high-rate and large-benefit mutations may have different long-term adaptive consequences. We show that small and 100-fold larger bacterial populations evolve resistance to a β-lactam antibiotic by using similar numbers, but different types of mutations. Small populations frequently substitute similar high-rate structural variants and loss-of-function point mutations, including the deletion of a low-activity β-lactamase, and evolve modest resistance levels. Large populations more often use low-rate, large-benefit point mutations affecting the same targets, including mutations activating the β-lactamase and other gain-of-function mutations, leading to much higher resistance levels. Our results demonstrate the separation by clonal interference of mutation classes with divergent adaptive consequences, causing a shift from high-rate to large-benefit mutations with increases in population size.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
There are no restrictions on data availability. Accession codes for reference sequences used are provided in Supplementary Information (REL606 genome: Genbank NC_012967.1; pACTEM1 plasmid: Genbank MN386081). Raw sequencing reads have been submitted to the NCBI Sequence Read Archive (https://www.ncbi.nlm.nih.gov/bioproject/PRJNA790633). Other data and code have been made available in Supplementary Information and at Dryad (https://doi.org/10.5061/dryad.b2rbnzsh2), and are organized per figure.
References
de Visser, J. A. G. M. & Krug, J. Empirical fitness landscapes and the predictability of evolution. Nat. Rev. Genet. 15, 480–490 (2014).
Lässig, M., Mustonen, V. & Walczak, A. M. Predicting evolution. Nat. Ecol. Evol. 1, 77 (2017).
Mas, A., Lagadeuc, Y. & Vandenkoornhuyse, P. Reflections on the predictability of evolution: toward a conceptual framework. iScience 23, 101736 (2020).
Palmer, A. C. & Kishony, R. Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nat. Rev. Genet. 14, 243–248 (2013).
Sommer, M. O. A. et al. Prediction of antibiotic resistance: time for a new preclinical paradigm? Nat. Rev. Microbiol. 15, 689–696 (2017).
Baym, M. et al. Spatiotemporal microbial evolution on antibiotic landscapes. Science 353, 1147–1151 (2016).
Good, B. H. et al. The dynamics of molecular evolution over 60,000 generations. Nature 551, 45–50 (2017).
Tenaillon, O. et al. The molecular diversity of adaptive convergence. Science 335, 457–461 (2012).
Sandegren, L. & Andersson, D. I. Bacterial gene amplification: implications for the evolution of antibiotic resistance. Nat. Rev. Genet. 7, 578–588 (2009).
Orr, H. A. The population genetics of beneficial mutations. Phil. Trans. R. Soc. B 365, 1195–1201 (2010).
Sniegowski, P. D. & Gerrish, P. J. Beneficial mutations and the dynamics of adaptation in asexual populations. Phil. Trans. R. Soc. B 365, 1255–1263 (2010).
Orr, H. A. The distribution of fitness effects among beneficial mutations. Genetics 163, 1519–1526 (2003).
Bailey, S. F. et al. What drives parallel evolution? BioEssays 39, e201600176 (2017).
Garoff, L. et al. Population bottlenecks strongly influence the evolutionary trajectory to fluoroquinolone resistance in Escherichia coli. Mol. Biol. Evol. 37, 1637–1646 (2020).
Storz.J. F. Causes of molecular convergence and parallelism in protein evolution. Nat. Rev. Genet. 17, 239–250 (2016).
Orr, H. A. The probability of parallel evolution. Evolution 59, 216–220 (2005).
Gerrish, P. J. & Lenski, R. E. The fate of competing beneficial mutations in an asexual population. Genetica 102, 127–144 (1998).
Good, B. H. et al. Distribution of fixed beneficial mutations and the rate of adaptation in asexual populations. Proc. Natl Acad. Sci. USA 109, 4950–4955 (2012).
Gomez, K., Bertram, J. & Masel, J. Mutation bias can shape adaptation in large asexual populations experiencing clonal interference. Proc. R. Soc. B 287, 20201503 (2020).
Payne, J. L. et al. Transition bias influences the evolution of antibiotic resistance in Mycobacterium tuberculosis. PLoS Biol. 17, e3000265 (2019).
Sackman, A. M. et al. Mutation-driven parallel evolution during viral adaptation. Mol. Biol. Evol. 34, 3243–3253 (2017).
Stoltzfus, A. & McCandlish, D. M. Mutational biases influence parallel adaptation. Mol. Biol. Evol. 34, 2163–2172 (2017).
Svensson, E. I. & Berger, D. The role of mutation bias in adaptive evolution. Trends Ecol. Evol. 34, 422–434 (2019).
MacLean, R. C., Perron, G. G. & Gardner, A. Diminishing returns from beneficial mutations and pervasive epistasis shape the fitness landscape for rifampicin resistance in Pseudomonas aeruginosa. Genetics 186, 1345–1354 (2010).
Storz, J. F. et al. The role of mutation bias in adaptive molecular evolution: insights from convergent changes in protein function. Phil. Trans. R. Soc. B 374, 20180238 (2019).
Ochs, I. E. & Desai, M. The competition between simple and complex evolutionary trajectories in asexual populations. BMC Evol. Biol. 15, 55 (2015).
Salverda, M. L. M. et al. Initial mutations direct alternative pathways of protein evolution. PLoS Genet. 7, e1001321 (2011).
Salverda, M. L. M. et al. Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme. Proc. Natl Acad. Sci. USA 114, 12773–12778 (2017).
Szendro, I. G. et al. Predictability of evolution depends non-monotonically on population size. Proc. Natl Acad. Sci. USA 110, 571–576 (2013).
Windels, E. M. et al. Population bottlenecks strongly affect the evolutionary dynamics of antibiotic persistence. Mol. Biol. Evol. 38, 3345–3357 (2021).
Mahrt, N. et al. Bottleneck size and selection level reproducibly impact antibiotic resistance evolution. Nat. Ecol. Evol. 5, 1233–1242 (2021).
Woods, R. J. et al. Second-order selection for evolvability in a large Escherichia coli population. Science 331, 1433–1436 (2011).
Consuegra, J. et al. Insertion-sequence-mediated mutations both promote and constrain evolvability during a long-term experiment with bacteria. Nat. Commun. 12, 980 (2021).
de Visser, J. A. G. M. et al. Diminishing returns from mutation supply rate in asexual populations. Science 283, 404–406 (1999).
Rozen, D. E. et al. Heterogeneous adaptive trajectories of small populations on complex fitness landscapes. PLoS ONE 3, e1715 (2008).
Salverda, M. L. M., de Visser, J. A. G. M. & Barlow, M. Natural evolution of TEM-1 beta-lactamase: experimental reconstruction and clinical relevance. FEMS Microbiol. Rev. 34, 1015–1036 (2010).
Woods, R. et al. Tests of parallel molecular evolution in a long-term experiment with Escherichia coli. Proc. Natl Acad. Sci. USA 103, 9107–9112 (2006).
Kim, S. W. et al. Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics. Sci. Rep. 8, 5402 (2018).
Andersson, D. I. & Hughes, D. Gene amplification and adaptive evolution in bacteria. Annu. Rev. Genet. 43, 167–195 (2009).
Lind, P. A. et al. Predicting mutational routes to new adaptive phenotypes. eLife 8, e38822 (2019).
Maddamsetti, R. et al. Core genes evolve rapidly in the long-term evolution experiment with Escherichia coli. Genome Biol. Evol. 9, 1072–1083 (2017).
Eyre-Walker, A. & Keightley, P. D. The distribution of fitness effects of new mutations. Nat. Rev. Genet. 8, 610–618 (2007).
Sanjuán, R., Moya, A. & Elena, S. F. The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc. Natl Acad. Sci. USA 101, 8396–8401 (2004).
Schenk, M. F. et al. Quantifying the adaptive potential of an antibiotic resistance enzyme. PLoS Genet. 8, e1002783 (2012).
Blank, D. et al. The predictability of molecular evolution during functional innovation. Proc. Natl Acad. Sci. USA 111, 3044–3049 (2014).
Chavhan, Y., Malusare, S. & Dey, S. Larger bacterial populations evolve heavier fitness trade-offs and undergo greater ecological specialization. Heredity 124, 726–736 (2020).
Pinheiro, F. et al. Metabolic fitness landscapes predict the evolution of antibiotic resistance. Nat. Ecol. Evol. 5, 677–687 (2021).
Raeside, C. et al. Large chromosomal rearrangements during a long-term evolution experiment with Escherichia coli. mBio 5, e01377-14 (2014).
Lopatkin, A. J. et al. Clinically relevant mutations in core metabolic genes confer antibiotic resistance. Science 371, eaba0862 (2021).
Nicoloff, H. et al. The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nat. Microbiol. 4, 504–514 (2019).
Lachapelle, J., Reid, J. & Colegrave, N. Repeatability of adaptation in experimental populations of different sizes. Proc. R. Soc. B 282, 20143033 (2015).
van Dijk, T. et al. Mutation supply and the repeatability of selection for antibiotic resistance. Phys. Biol. 14, 055005 (2017).
Miller, C. R., Joyce, P. & Wichman, H. A. Mutational effects and population dynamics during viral adaptation challenge current models. Genetics 187, 185–202 (2011).
Lenski, R. E. et al. Long-term experimental evolution in Escherichia coli. I. Adaptation and divergence during 2,000 generations. Am. Nat. 138, 1315–1341 (1991).
Barlow, M. & Hall, B. G. Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the TEM beta-lactamase. Genetics 160, 823–832 (2002).
Lewontin, R. C. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49, 49–67 (1964).
Acknowledgements
We thank B. Koopmanschap (deceased) for practical help, and D. Aanen, S.-C. Park, S. Das, M. Lässig and A. Stoltzfus for comments and discussion. This work was supported by DFG grant SFB680 to M.F.S., M.P.Z., S.H., J.K. and J.A.G.M.d.V.; DFG grant CRC1310 to J.K. and J.A.G.M.d.V.; HFSP Research Grant RGP0010/2015 to P.R. and J.A.G.M.d.V.; and an EMBO fellowship (ALTF 273-2017) to P.R. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.
Author information
Authors and Affiliations
Contributions
M.F.S. and J.A.G.M.d.V. conceptualized the study; M.F.S., J.K. and J.A.G.M.d.V. designed the experiments; M.F.S., M.P.Z. and P.R. conducted the experiments; M.F.S., M.P.Z., S.H., P.R., E.S., J.K. and J.A.G.M.d.V analysed the data; M.F.S., M.P.Z., P.R., J.K. and J.A.G.M.d.V wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Ecology & Evolution thanks Craig MacLean, Isabel Gordo and Philip Gerrish for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 CTX concentrations during the evolution experiment.
CTX concentrations during the evolution experiment based on daily 20.25-fold increases when the OD600 was higher than 75% of the ancestral value without CTX (see text). Red lines represent small populations (S), blue lines large populations (L). Shades and line types have been varied randomly to better distinguish replicate populations. Note that for one large population the CTX concentration was increased during every round of passaging, as the cultures always reached a high density. For two other large populations, this was the case on all but one round of passaging.
Extended Data Fig. 2 Histogram of the number of mutations per clone.
Histogram of the number of mutations per clone, for all 112 populations.
Extended Data Fig. 3 Mutation frequency per mutation class and treatment.
Mutation frequency per mutation class and per treatment for the 107 non-mutator populations. Error bars indicate the standard error of the mean. SNPs are green, Indels are blue, and SVs are purple. Error bars indicate the standard error of the mean.
Extended Data Fig. 4 Gene-level H-indexes.
(a) Gene-level H-index is given for all mutational events in clones from non-mutator populations. (b) Gene-level H-index is given for three classes of mutational events, as indicated by the legend.
Extended Data Fig. 5 Regression analysis of the fraction of SVs against CTX concentration.
Regression analysis of the fraction of SVs among all mutations per clone against CTX concentration.
Extended Data Fig. 6 Distribution of predicted and observed mutations in the final clones.
Distribution of fixed mutations at the evolutionary endpoint obtained from the optimized WF model in comparison to the experimental data. Column heights represent the mean number of mutations and error bars show the corresponding standard deviation.
Supplementary information
Supplementary Information
Combined supplementary material, including additional methods, statistical and theoretical analyses, and results; it includes 13 figures and 14 tables.
Rights and permissions
About this article
Cite this article
Schenk, M.F., Zwart, M.P., Hwang, S. et al. Population size mediates the contribution of high-rate and large-benefit mutations to parallel evolution. Nat Ecol Evol 6, 439–447 (2022). https://doi.org/10.1038/s41559-022-01669-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41559-022-01669-3
This article is cited by
-
Intrahost evolution of the gut microbiota
Nature Reviews Microbiology (2023)
-
Population size matters for mutations
Nature Ecology & Evolution (2022)